Analysts see continued financial growth for McKesson with ne...

Analysts see continued financial growth for McKesson with new drug approvals adding revenue streams. Shares at 15.6 times forward earnings remain attractive. Strong return on equity and invested capital highlight difficult-to-copy distribution setup.